What's new

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

Central Nervous System Working Party

Next Article

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Da...

Related Posts

Herbal medicinal product: Hyperici herbaArray,Array, D: Draft under discussion

Herbal medicinal product: Hyperici herbaArray,Array, D:...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Summary of opinion: Keytruda, 27/02/2025 Positive

Summary of opinion: Keytruda, 27/02/2025 Positive

Feb 28, 2025  0